Possible Oncogenic Viruses Associated with Lung Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proceedings. 2008;83(5):584–594.18452692
   PubMed Web of Science ®Google Scholar
• Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: american College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5Suppl):e1S–e29S.23649439
   PubMedGoogle Scholar
• Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers–a different disease. Nat Rev Cancer. 2007;7(10):778–790.17882278
   PubMed Web of Science ®Google Scholar
• Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10(12):878–889.21102637
   PubMed Web of Science ®Google Scholar
• Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14(6):453–471.15489139
   PubMed Web of Science ®Google Scholar
• Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget. 2017;8(56):96419–96432.29221217
   PubMedGoogle Scholar
• Robinson LA, Jaing CJ, Pierce Campbell C, et al. Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br J Cancer. 2016;115(4):497–504.27415011
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Ando M, Kubo A, et al. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer. 2014;83(1):8–13.24252423
   PubMed Web of Science ®Google Scholar
• Hashida Y, Imajoh M, Nemoto Y, et al. Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer. 2013;108(3):629–637. doi:10.1038/bjc.2012.56723322199
   PubMed Web of Science ®Google Scholar
• Behdarvand A, Zamani MS, Sadeghi F, et al. Evaluation of Merkel cell polyomavirus in non-small cell lung cancer and adjacent normal cells. Microb Pathog. 2017;108:21–26. doi:10.1016/j.micpath.2017.04.03328455138
   PubMed Web of Science ®Google Scholar
• Lasithiotaki I, Tsitoura E, Koutsopoulos A, et al. Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer. Oncotarget. 2017;8(68):112371–112383. doi:10.18632/oncotarget.1122229348831
   PubMedGoogle Scholar
• Yeh Y-C, Kao H-L, Lee K-L, Wu M-H, Ho H-L, Chou T-Y. Epstein-Barr Virus–Associated Pulmonary Carcinoma. Am J Surg Pathol. 2019;43(2):211–219. doi:10.1097/PAS.000000000000117330334830
   PubMed Web of Science ®Google Scholar
• Xie M, Wu X, Wang F, et al. Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients. J Thoracic Oncol. 2018;13(2):218–227. doi:10.1016/j.jtho.2017.10.031
   PubMed Web of Science ®Google Scholar
• Wang S, Xiong H, Yan S, Wu N, Lu Z. Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology. Sci Rep. 2016;6(1):26156. doi:10.1038/srep2615627189712
   PubMedGoogle Scholar
• Monot M, Archer F, Gomes M, Mornex J-F, Leroux C. Advances in the study of transmissible respiratory tumours in small ruminants. Vet Microbiol. 2015;181(1–2):170–177. doi:10.1016/j.vetmic.2015.08.00826340900
   PubMed Web of Science ®Google Scholar
• De Paoli P, Carbone A. Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int j Cancer. 2013;133(7):1517–1529.23280523
   PubMed Web of Science ®Google Scholar
• Syrjanen KJ. Condylomatous changes in neoplastic bronchial epithelium. Rep Case Respiration. 1979;38(5):299–304.
   Google Scholar
• Syrjanen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012;32(8):3235–3250.22843898
   PubMed Web of Science ®Google Scholar
• Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61(7):2799–2803.11306446
   PubMed Web of Science ®Google Scholar
• Nadji SA, Mokhtari-Azad T, Mahmoodi M, et al. Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett. 2007;248(1):41–46.16814459
   PubMed Web of Science ®Google Scholar
• Sarchianaki E, Derdas SP, Ntaoukakis M, et al. Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol. 2014;35(4):3203–3209.24310500
   PubMedGoogle Scholar
• Chen SP, Hsu NY, Wu JY, et al. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients. Ann Thorac Surg. 2013;95(4):1196–1203.23522190
   PubMed Web of Science ®Google Scholar
• de Oliveira THA, do Amaral CM, de Franca Sao Marcos B, Nascimento KCG, de Miranda Rios AC, Quixabeira DCA, et al. Presence and activity of HPV in primary lung cancer. J Cancer Res Clin Oncol. 2018;144(12):2367–2376.30225539
   PubMedGoogle Scholar
• Fei Y, Yang J, Hsieh WC, et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol. 2006;36(5):274–279.16690730
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang A, Jiang R, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China. Oncol Rep. 2008;20(2):333–339.18636194
   PubMed Web of Science ®Google Scholar
• Wang YH, Chen DJ, Yi TN, Liu XH. The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue. Saudi Med J. 2010;31(12):1331–1336.21135996
   PubMed Web of Science ®Google Scholar
• Yu Y, Yang A, Hu S, Zhang J, Yan H. Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas. Clin Respir J. 2013;7(1):27–33.22171791
   PubMed Web of Science ®Google Scholar
• Badillo-Almaraz I, Zapata-Benavides P, Saavedra-Alonso S, et al. Human papillomavirus 16/18 infections in lung cancer patients in Mexico. Intervirology. 2013;56(5):310–315.23942143
   PubMed Web of Science ®Google Scholar
• Cheng YW, Wu MF, Wang J, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res. 2007;67(22):10686–10693.18006810
   PubMed Web of Science ®Google Scholar
• Kato T, Koriyama C, Khan N, et al. EGFR mutations and human papillomavirus in lung cancer. Lung Cancer. 2012;78(2):144–147.22975156
   PubMed Web of Science ®Google Scholar
• Lin FC, Huang JY, Tsai SC, et al. The association between human papillomavirus infection and female lung cancer: A population-based cohort study. Medicine. 2016;95(23):e3856.27281096
   PubMed Web of Science ®Google Scholar
• Tung MC, Wu HH, Cheng YW, et al. Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer. Cancer. 2013;119(18):3367–3376.23797467
   PubMed Web of Science ®Google Scholar
• Wang JL, Fang CL, Wang M, et al. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma. Int j Cancer. 2014;134(1):65–71.23797776
   PubMed Web of Science ®Google Scholar
• Storey R, Joh J, Kwon A, Jenson AB, Ghim SJ, Kloecker GH. Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer. J Oncol. 2013;2013:240164.23533408
   PubMedGoogle Scholar
• Aguayo F, Castillo A, Koriyama C, et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer. 2007;97(1):85–91.17579626
   PubMed Web of Science ®Google Scholar
• Anantharaman D, Gheit T, Waterboer T, et al. No causal association identified for human papillomavirus infections in lung cancer. Cancer Res. 2014;74(13):3525–3534.24760422
   PubMed Web of Science ®Google Scholar
• Argyri E, Tsimplaki E, Marketos C, Politis G, Panotopoulou E. Investigating the role of human papillomavirus in lung cancer. Papillomavirus Res. 2017;3:7–10.28720459
   PubMedGoogle Scholar
• van Boerdonk RA, Daniels JM, Bloemena E, et al. High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis. J Thoracic Oncol. 2013;8(6):711–718.
   PubMed Web of Science ®Google Scholar
• Galvan A, Noci S, Taverna F, et al. Testing of human papillomavirus in lung cancer and non-tumor lung tissue. BMC Cancer. 2012;12:512.23140419
   PubMed Web of Science ®Google Scholar
• Chang SY, Keeney M, Law M, Donovan J, Aubry MC, Garcia J. Detection of human papillomavirus in non-small cell carcinoma of the lung. Hum Pathol. 2015;46(11):1592–1597.26342243
   PubMed Web of Science ®Google Scholar
• Lim WT, Chuah KL, Leong SS, Tan EH, Toh CK. Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma. Oncol Rep. 2009;21(4):971–975.19287995
   PubMed Web of Science ®Google Scholar
• Silva EM, Mariano VS, Pastrez PRA, et al. Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study. Infect Agent Cancer. 2019;14:18.31388352
   PubMed Web of Science ®Google Scholar
• Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–664.25299412
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Koutelou A, Natalicchio MI, et al. HPV in exhaled breath condensate of lung cancer patients. Br J Cancer. 2011;105(8):1183–1190.21952627
   PubMed Web of Science ®Google Scholar
• Chiou HL, Wu MF, Liaw YC, et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer. 2003;97(6):1558–1563.12627521
   PubMed Web of Science ®Google Scholar
• Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM. Could human papillomaviruses be spread through blood? J Clin Microbiol. 2005;43(11):5428–5434.16272465
   PubMed Web of Science ®Google Scholar
• Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis. J Clin Virology. 2015;63:84–90.25315992
   PubMed Web of Science ®Google Scholar
• Mammas IN, Sourvinos G, Spandidos DA. The paediatric story of human papillomavirus (Review). Oncol Lett. 2014;8(2):502–506.25013461
   PubMed Web of Science ®Google Scholar
• Gillison ML, Shah KV. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003;31:57–65.
   Google Scholar
• Chen HB, Chen L, Zhang JK, et al. Human papillomavirus 16 E6 is associated with the nuclear matrix of esophageal carcinoma cells. World j Gastroenterol. 2001;7(6):788–791.11854902
   PubMed Web of Science ®Google Scholar
• Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol. 2002;55(12):885–891.12461047
   PubMed Web of Science ®Google Scholar
• Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992;136(1):54–58.1329500
   PubMed Web of Science ®Google Scholar
• Frisch M, Melbye M. Risk of lung cancer in pre- and post-menopausal women with ano-genital malignancies. Int j Cancer. 1995;62(5):508–511.7665218
   PubMedGoogle Scholar
• Li YJ, Tsai YC, Chen YC, Christiani DC. Human papilloma virus and female lung adenocarcinoma. Semin Oncol. 2009;36(6):542–552.19995646
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hu X, Zhou J, Zhao M, Zhu X, Zhu X. Human papillomavirus DNA in surgical smoke during cervical loop electrosurgical excision procedures and its impact on the surgeon. Cancer Manag Res. 2019;11:3643–3654.31118787
   PubMed Web of Science ®Google Scholar
• Schiller JT, Day PM, Kines RC. Current understanding of the mechanism of HPV infection. Gynecol Oncol. 2010;118(1 Suppl):S12–S27.20494219
   PubMedGoogle Scholar
• Smits NC, Shworak NW, Dekhuijzen PN, van Kuppevelt TH. Heparan sulfates in the lung: structure, diversity, and role in pulmonary emphysema. Anatomical Record. 2010;293(6):955–967.
   Google Scholar
• Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A. 2009;106(48):20458–20463.19920181
   PubMed Web of Science ®Google Scholar
• Hammond E, Khurana A, Shridhar V, Dredge K. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics. Front Oncol. 2014;4:195.25105093
   PubMedGoogle Scholar
• Kines RC, Cerio RJ, Roberts JN, et al. Human papillomavirus capsids preferentially bind and infect tumor cells. Int j Cancer. 2016;138(4):901–911.26317490
   PubMed Web of Science ®Google Scholar
• Chen PM, Cheng YW, Wang YC, Wu TC, Chen CY, Lee H. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis. Neoplasia. 2014;16(11):961–971.25425970
   PubMed Web of Science ®Google Scholar
• Wu DW, Tsai LH, Chen PM, et al. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer. Am J Pathol. 2012;181(5):1796–1806.22982189
   PubMed Web of Science ®Google Scholar
• Hsu NY, Cheng YW, Chan IP, et al. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep. 2009;21(1):81–87.19082446
   PubMed Web of Science ®Google Scholar
• Iwamasa T, Miyagi J, Tsuhako K, et al. Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol Res Pract. 2000;196(4):209–218.10782464
   PubMed Web of Science ®Google Scholar
• Miyagi J, Kinjo T, Tsuhako K, et al. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology. 2001;38(4):355–367.11318901
   PubMed Web of Science ®Google Scholar
• Guo L, Liu S, Zhang S, et al. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8(21):34507–34515.28427144
   PubMedGoogle Scholar
• Jackson AL, Zhou B, Kim WY. HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer. Expert Opin Ther Targets. 2010;14(10):1047–1057.20854179
   PubMed Web of Science ®Google Scholar
• Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;8(8):579–591.18596824
   PubMed Web of Science ®Google Scholar
• Zhang E, Feng X, Liu F, Zhang P, Liang J, Tang X. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1alpha, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One. 2014;9(7):e103440.25058399
   PubMed Web of Science ®Google Scholar
• Li G, He L, Zhang E, et al. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1alpha and VEGF expression in non-small cell lung cancer cells. Cancer Lett. 2011;311(2):160–170.21868151
   PubMed Web of Science ®Google Scholar
• Liu J, Huang B, Xiu Z, et al. PI3K/Akt/HIF-1alpha signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells. J Cancer. 2018;9(19):3456–3466.30310502
   PubMed Web of Science ®Google Scholar
• Gu NJ, Wu MZ, He L, et al. HPV 16 E6/E7 up-regulate the expression of both HIF-1alpha and GLUT1 by inhibition of RRAD and activation of NF-kappaB in lung cancer cells. J Cancer. 2019;10(27):6903–6909.31839825
   PubMed Web of Science ®Google Scholar
• Fan R, Hou WJ, Zhao YJ, et al. Overexpression of HPV16 E6/E7 mediated HIF-1alpha upregulation of GLUT1 expression in lung cancer cells. Tumour Biol. 2016;37(4):4655–4663.26508030
   PubMedGoogle Scholar
• Joshi S, Singh AR, Zulcic M, Durden DL. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1alpha and HIF2alpha stability and tumor growth, angiogenesis, and metastasis. Mol Cancer Res. 2014;12(10):1520–1531.25103499
   PubMed Web of Science ®Google Scholar
• Shao JS, Sun J, Wang S, et al. HPV16 E6/E7 upregulates HIF-2alpha and VEGF by inhibiting LKB1 in lung cancer cells. Tumour Biol. 2017;39(7):1010428317717137.28720067
   PubMedGoogle Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67.20371345
   PubMed Web of Science ®Google Scholar
• Shiau MY, Fan LC, Yang SC, et al. Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas. PLoS One. 2013;8(1):e54423.23349885
   PubMed Web of Science ®Google Scholar
• Chetty C, Lakka SS, Bhoopathi P, Kunigal S, Geiss R, Rao JS. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. Cancer Res. 2008;68(12):4736–4745.18559520
   PubMed Web of Science ®Google Scholar
• Barski D, Wolter M, Reifenberger G, Riemenschneider MJ. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol. 2010;20(3):623–631.19922547
   PubMed Web of Science ®Google Scholar
• Wild A, Langer P, Celik I, Chaloupka B, Bartsch DK. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur j Endocrinol. 2002;147(4):507–513.12370114
   PubMed Web of Science ®Google Scholar
• Nakamura M, Ishida E, Shimada K, et al. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. Lab Invest. 2005;85(2):165–175.15592495
   PubMed Web of Science ®Google Scholar
• Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis. 2003;24(7):1167–1176.12807729
   PubMed Web of Science ®Google Scholar
• Lantuejoul S, Soria JC, Morat L, et al. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions. Clin Cancer Res. 2005;11(5):2074–2082.15756034
   PubMed Web of Science ®Google Scholar
• Cheng YW, Wu TC, Chen CY, Chou MC, Ko JL, Lee H. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Clin Cancer Res. 2008;14(22):7173–7179.19010833
   PubMed Web of Science ®Google Scholar
• Xu D, Wang Q, Gruber A, et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene. 2000;19(45):5123–5133.11064449
   PubMed Web of Science ®Google Scholar
• Yang JH, Li XY, Wang X, et al. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells. PLoS One. 2017;12(8):e0182775.28813465
   PubMed Web of Science ®Google Scholar
• Martinez-Zapien D, Ruiz FX, Poirson J, et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529(7587):541–545.26789255
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342–350.12044010
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501–1512.10385618
   PubMed Web of Science ®Google Scholar
• el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75(4):817–825.8242752
   PubMed Web of Science ®Google Scholar
• Marchetti A, Doglioni C, Barbareschi M, et al. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene. 1996;12(6):1319–1324.8649834
   PubMed Web of Science ®Google Scholar
• Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993;7(7A):1126–1132.8319905
   PubMed Web of Science ®Google Scholar
• Rosner A, Rinkevich B. The DDX3 subfamily of the DEAD box helicases: divergent roles as unveiled by studying different organisms and in vitro assays. Curr Med Chem. 2007;14(23):2517–2525.17979704
   PubMed Web of Science ®Google Scholar
• Wu DW, Liu WS, Wang J, Chen CY, Cheng YW, Lee H. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer. Clin Cancer Res. 2011;17(7):1895–1905.21325288
   PubMed Web of Science ®Google Scholar
• Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2(2):103–112.12204530
   PubMed Web of Science ®Google Scholar
• Ulivi P, Zoli W, Calistri D, et al. p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. J Cell Physiol. 2006;206(3):611–615.16222700
   PubMed Web of Science ®Google Scholar
• Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59(1):67–70.9892187
   PubMed Web of Science ®Google Scholar
• Finzer P, Kuntzen C, Soto U, et al. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene. 2001;20(35):4768–4776.11521189
   PubMed Web of Science ®Google Scholar
• Wu M-F, Cheng Y-W, Lai J-C, et al. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int j Cancer. 2005;113(3):440–445. doi:10.1002/ijc.2059715455389
   PubMed Web of Science ®Google Scholar
• Lin T-S, Lee H, Chen R-A, et al. An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection. Cancer Lett. 2005;226(1):77–84. doi:10.1016/j.canlet.2004.12.03116004934
   PubMed Web of Science ®Google Scholar
• Sozzi G, Veronese ML, Negrini M, et al. The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer. Cell. 1996;85(1):17–26. doi:10.1016/S0092-8674(00)81078-88620533
   PubMed Web of Science ®Google Scholar
• Wang J, Cheng Y-W, Wu D-W, et al. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan. Cancer Lett. 2006;235(1):18–25. doi:10.1016/j.canlet.2005.03.05815935551
   PubMed Web of Science ®Google Scholar
• Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 1998;58(22):5032–5037.9823304
   PubMed Web of Science ®Google Scholar
• Burke L, Khan MA, Freedman AN, et al. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res. 1998;58(12):2533–2536.9635574
   PubMed Web of Science ®Google Scholar
• Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet. 1996;5(2):187–195. doi:10.1093/hmg/5.2.1878824874
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Lacedonia D, Crisetti E, et al. Exhaled HPV infection in lung cancer: role of MA at 3p. Arch Med Res. 2014;45(5):383–387. doi:10.1016/j.arcmed.2014.06.00624962429
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu X, Yang Y, et al. Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development. Oncol Lett. 2015;10(1):392–398. doi:10.3892/ol.2015.321326171037
   PubMed Web of Science ®Google Scholar
• Verri C, Roz L, Conte D, et al. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med. 2009;179(5):396–401. doi:10.1164/rccm.200807-1153OC19096006
   PubMed Web of Science ®Google Scholar
• Liang H, Pan Z, Cai X, et al. The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer. Translational Lung Cancer Res. 2018;7(3):397–403. doi:10.21037/tlcr.2018.03.16
   PubMed Web of Science ®Google Scholar
• Baba M, Castillo A, Koriyama C, et al. Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep. 2010;23(4):1085–1092.20204295
   PubMed Web of Science ®Google Scholar
• Li M, Deng F, Qian L-T, et al. Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma. Oncol Lett. 2016;12(3):1953–1958. doi:10.3892/ol.2016.484727602120
   PubMed Web of Science ®Google Scholar
• Marquez-Medina D, Gasol-Cudos A, Taberner-Bonastre MT, Samame Perez-Vargas JC, Salud-Salvia A, Llombart-Cussac A. Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib. Archivos de Bronconeumología (English Edition). 2013;49(2):79–81. doi:10.1016/j.arbr.2012.04.006
   PubMed Web of Science ®Google Scholar
• Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004;64(20):7183–7190. doi:10.1158/0008-5472.CAN-04-191815492230
   PubMed Web of Science ®Google Scholar
• Wu -H-H, Wu J-Y, Cheng Y-W, et al. cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer. Clin Cancer Res. 2010;16(21):5200–5210. doi:10.1158/1078-0432.CCR-10-002020959404
   PubMed Web of Science ®Google Scholar
• Kawahara A, Azuma K, Hattori S, et al. The close correlation between 8-hydroxy-2ʹ-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer. Hum Pathol. 2010;41(7):951–959.20236686
   PubMed Web of Science ®Google Scholar
• Munoz JP, Gonzalez C, Parra B, et al. Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells. PLoS One. 2012;7(5):e38178. doi:10.1371/journal.pone.003817822662279
   PubMed Web of Science ®Google Scholar
• Pena N, Carrillo D, Munoz JP, et al. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS One. 2015;10(4):e0123029. doi:10.1371/journal.pone.012302925830243
   PubMed Web of Science ®Google Scholar
• Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis. 2001;22(12):1903–1930. doi:10.1093/carcin/22.12.190311751421
   PubMed Web of Science ®Google Scholar
• Alam S, Conway MJ, Chen H-S, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol. 2008;82(2):1053–1058. doi:10.1128/JVI.01813-0717989183
   PubMed Web of Science ®Google Scholar
• Lee M-N, Tseng R-C, Hsu H-S, et al. Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer. Clin Cancer Res. 2007;13(3):832–838. doi:10.1158/1078-0432.CCR-05-269417289874
   PubMed Web of Science ®Google Scholar
• Johansson F. A method to monitor replication fork progression in mammalian cells: nucleotide excision repair enhances and homologous recombination delays elongation along damaged DNA. Nucleic Acids Res. 2004;32(20):e157. doi:10.1093/nar/gnh15415537835
   PubMed Web of Science ®Google Scholar
• Cheng Y-W, Lin FC-F, Chen C-Y, Hsu N-Y. Environmental exposure and HPV infection may act synergistically to induce lung tumorigenesis in nonsmokers. Oncotarget. 2016;7(15):19850–19862. doi:10.18632/oncotarget.762826918347
   PubMedGoogle Scholar
• De Blasio A, Vento R, Di Fiore R. Mcl-1 targeting could be an intriguing perspective to cure cancer. J Cell Physiol. 2018;233(11):8482–8498. doi:10.1002/jcp.2678629797573
   PubMed Web of Science ®Google Scholar
• Chang Y-H, Yu C-W, Lai L-C, et al. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer. Cancer. 2010;116(20):4800–4809. doi:10.1002/cncr.2522420578176
   PubMed Web of Science ®Google Scholar
• Cheng Y-W, Lee H, Shiau M-Y, Wu T-C, Huang -T-T, Chang Y-H. Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer. Clin Cancer Res. 2008;14(15):4705–4712. doi:10.1158/1078-0432.CCR-07-467518676738
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang J, Cui X, et al. FoxM1: a novel tumor biomarker of lung cancer. Int J Clin Exp Med. 2015;8(3):3136–3140.26064203
   PubMed Web of Science ®Google Scholar
• Luscher-Firzlaff JM, Westendorf JM, Zwicker J, et al. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene. 1999;18(41):5620–5630. doi:10.1038/sj.onc.120296710523841
   PubMed Web of Science ®Google Scholar
• Xia Y, Chen Q, Zhong Z, et al. Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem. 2013;32(2):476–485. doi:10.1159/00035445223988701
   PubMedGoogle Scholar
• Wu Y-L, Hsu N-Y, Cheau-Feng Lin F, Lee H, Cheng Y-W. MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer. Surgery. 2016;160(6):1591–1598. doi:10.1016/j.surg.2016.06.02527506865
   PubMed Web of Science ®Google Scholar
• Christensen ND, Budgeon LR, Cladel NM, Hu J. Recent advances in preclinical model systems for papillomaviruses. Virus Res. 2017;231:108–118. doi:10.1016/j.virusres.2016.12.00427956145
   PubMed Web of Science ®Google Scholar
• Carraresi L, Tripodi SA, Mulder LC, et al. Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes. Oncogene. 2001;20(56):8148–8153. doi:10.1038/sj.onc.120500711781829
   PubMed Web of Science ®Google Scholar
• Carraresi L, Martinelli R, Vannoni A, et al. Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. Cancer Lett. 2006;231(1):65–73. doi:10.1016/j.canlet.2005.01.02716356832
   PubMed Web of Science ®Google Scholar
• Vonsky MS, Runov AL, Gordeychuk IV, Isaguliants MG. Therapeutic Vaccines Against Human Papilloma Viruses: achievements and Prospects. Biochemistry (Moscow). 2019;84(7):800–816. doi:10.1134/S000629791907010131509730
   PubMed Web of Science ®Google Scholar
• Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–1100.18202256
   PubMed Web of Science ®Google Scholar
• Pantulu ND, Pallasch CP, Kurz AK, et al. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood. 2010;116(24):5280–5284. doi:10.1182/blood-2010-02-26982920817850
   PubMed Web of Science ®Google Scholar
• Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, Toland AE. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol. 2009;129(12):2868–2874. doi:10.1038/jid.2009.18319554019
   PubMed Web of Science ®Google Scholar
• Imajoh M, Hashida Y, Nemoto Y, et al. Detection of Merkel cell polyomavirus in cervical squamous cell carcinomas and adenocarcinomas from Japanese patients. Virol J. 2012;9(1):154. doi:10.1186/1743-422X-9-15422876976
   PubMedGoogle Scholar
• Sadeghi F, Salehi-Vaziri M, Alizadeh A, et al. Detection of Merkel cell polyomavirus large T-antigen sequences in human central nervous system tumors. J Med Virol. 2015;87(7):1241–1247. doi:10.1002/jmv.2417825754536
   PubMed Web of Science ®Google Scholar
• Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe. 2010;7(6):509–515. doi:10.1016/j.chom.2010.05.00620542254
   PubMed Web of Science ®Google Scholar
• Babakir-Mina M, Ciccozzi M, Lo Presti A, Greco F, Perno CF, Ciotti M. Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol. 2010;82(3):505–509. doi:10.1002/jmv.2171120087943
   PubMed Web of Science ®Google Scholar
• Mancuso G, Antona J, Sirini C, et al. Frequent detection of Merkel cell polyomavirus DNA in tissues from 10 consecutive autopsies. J Gen Virol. 2017;98(6):1372–1376. doi:10.1099/jgv.0.00077828613147
   PubMed Web of Science ®Google Scholar
• van der Heijden HFM, Heijdra YF. Extrapulmonary small cell carcinoma. South Med J. 2005;98(3):345–349. doi:10.1097/01.SMJ.0000145724.40477.5015813162
   PubMed Web of Science ®Google Scholar
• Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol. 2009;16(3):135–144. doi:10.1097/PAP.0b013e3181a12f5a19395876
   PubMed Web of Science ®Google Scholar
• Andres C, Ihrler S, Puchta U, Flaig MJ. Merkel cell polyomavirus is prevalent in a subset of small cell lung cancer: a study of 31 patients. Thorax. 2009;64(11):1007–1008. doi:10.1136/thx.2009.117911
   PubMed Web of Science ®Google Scholar
• Helmbold P, Lahtz C, Herpel E, Schnabel PA, Dammann RH. Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer. 2009;45(12):2207–2211. doi:10.1016/j.ejca.2009.04.03819473831
   PubMed Web of Science ®Google Scholar
• Wetzels CTAH, Hoefnagel JGM, Bakkers JMJE, Dijkman HBPM, Blokx WAM, Melchers WJG. Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung. PLoS One. 2009;4(3):e4958. doi:10.1371/journal.pone.000495819305499
   PubMed Web of Science ®Google Scholar
• Karimi S, Yousefi F, Seifi S, Khosravi A, Nadji SA. No evidence for a role of Merkel cell polyomavirus in small cell lung cancer among Iranian subjects. Pathology - Research and Practice. 2014;210(12):836–839. doi:10.1016/j.prp.2014.08.011
   PubMed Web of Science ®Google Scholar
• Lasithiotaki I, Antoniou KM, Derdas SP, et al. The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer. Int j Cancer. 2013;133(3):604–611. doi:10.1002/ijc.2806223355004
   PubMed Web of Science ®Google Scholar
• Joh J, Jenson AB, Moore GD, et al. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol. 2010;89(3):222–226. doi:10.1016/j.yexmp.2010.08.00120699096
   PubMed Web of Science ®Google Scholar
• Gheit T, Munoz JP, Levican J, et al. Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol. 2012;93(1):162–166. doi:10.1016/j.yexmp.2012.04.00822537543
   PubMed Web of Science ®Google Scholar
• Xu S, Jiang J, Yu X, Sheng D, Zhu T, Jin M. Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients. Lung Cancer. 2014;83(3):341–346.24485957
   PubMed Web of Science ®Google Scholar
• Kim G-J, Lee J-H, Lee DH. Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer. Medicine. 2017;96(3):e5413. doi:10.1097/MD.000000000000541328099328
   PubMed Web of Science ®Google Scholar
• Becker M, Dominguez M, Greune L, et al. Infectious Entry of Merkel Cell Polyomavirus. J Virol. 2019;93(6):6. doi:10.1128/JVI.02004-18
   Web of Science ®Google Scholar
• Samimi M, Kervarrec T, Touze A. Immunobiology of Merkel cell carcinoma. Curr Opin Oncol. 2020;32(2):114–121. doi:10.1097/CCO.000000000000060831972727
   PubMed Web of Science ®Google Scholar
• Paik PK, Arcila ME, Fara M, et al. Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J clin oncol. 2011;29(15):2046–2051.21483012
   PubMed Web of Science ®Google Scholar
• Brambilla E, Negoescu A, Gazzeri S, et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol. 1996;149(6):1941–1952.8952529
   PubMed Web of Science ®Google Scholar
• Chang CM, Yu KJ, Mbulaiteye SM, Hildesheim A, Bhatia K. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res. 2009;143(2):209–221. doi:10.1016/j.virusres.2009.07.00519596032
   PubMed Web of Science ®Google Scholar
• Deyrup AT. Epstein-Barr virus–associated epithelial and mesenchymal neoplasms. Hum Pathol. 2008;39(4):473–483. doi:10.1016/j.humpath.2007.10.03018342658
   PubMed Web of Science ®Google Scholar
• Kheir F, Zhao M, Strong MJ, et al. Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer. Cancers. 2019;11(6):6. doi:10.3390/cancers11060759
   Web of Science ®Google Scholar
• Lin Z, Situ D, Chang X, et al. Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma. Interact Cardiovasc Thorac Surg. 2016;23(1):41–46.26993476
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012;118(19):4748–4758. doi:10.1002/cncr.2745222359203
   PubMed Web of Science ®Google Scholar
• Chang Y-L, Wu C-T, Shih J-Y, Lee Y-C. Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas. Cancer Sci. 2011;102(1):282–287. doi:10.1111/j.1349-7006.2010.01768.x21070477
   PubMed Web of Science ®Google Scholar
• Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• Chu PG, Cerilli L, Chen -Y-Y, Mills SE, Weiss LM. Epstein–Barr virus plays no role in the tumorigenesis of small-cell carcinoma of the lung. Modern Pathol. 2004;17(2):158–164. doi:10.1038/modpathol.3800024
   PubMed Web of Science ®Google Scholar
• Gomez-Roman JJ, Martinez MN, Fernandez SL, Val-Bernal JF. Epstein–Barr virus-associated adenocarcinomas and squamous-cell lung carcinomas. Modern Pathol. 2009;22(4):530–537. doi:10.1038/modpathol.2009.7
   PubMed Web of Science ®Google Scholar
• Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell. 1987;50(2):203–213.3036369
   PubMed Web of Science ®Google Scholar
• Timens W, Boes A, Vos H, Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry. 1991;95(6):605–611.1830299
   PubMedGoogle Scholar
• Malizia AP, Egan JJ, Doran PPIL-4. increases CD21-dependent infection of pulmonary alveolar epithelial type II cells by EBV. Mol Immunol. 2009;46(8–9):1905–1910.19193442
   PubMed Web of Science ®Google Scholar
• Ngan RK, Yip TT, Cheng WW, et al. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung. Ann N Y Acad Sci. 2004;1022:263–270.15251971
   PubMed Web of Science ®Google Scholar
• Ngan RK, Yip TT, Cheng WW, et al. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease. Clin Cancer Res. 2002;8(4):986–994.
   PubMed Web of Science ®Google Scholar
• Gray ME, Meehan J, Sullivan P, et al. Ovine Pulmonary Adenocarcinoma: A Unique Model to Improve Lung Cancer Research. Front Oncol. 2019;9:335.31106157
   PubMed Web of Science ®Google Scholar
• Youssef G, Wallace WA, Dagleish MP, Cousens C, Griffiths DJ. Ovine pulmonary adenocarcinoma: a large animal model for human lung cancer. ILAR j. 2015;56(1):99–115.25991702
   PubMed Web of Science ®Google Scholar
• Martineau HM, Cousens C, Imlach S, Dagleish MP, Griffiths DJ. Jaagsiekte sheep retrovirus infects multiple cell types in the ovine lung. J Virol. 2011;85(7):3341–3355.21270155
   PubMed Web of Science ®Google Scholar
• Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A. 2001;98(8):4443–4448.11296287
   PubMed Web of Science ®Google Scholar
• De Las Heras M, Barsky SH, Hasleton P, et al. Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J. 2000;16(2):330–332.10968511
   PubMed Web of Science ®Google Scholar
• Linnerth-Petrik NM, Walsh SR, Bogner PN, Morrison C, Wootton SK. Jaagsiekte sheep retrovirus detected in human lung cancer tissue arrays. BMC Res Notes. 2014;7:160.24642139
   PubMedGoogle Scholar
• Rocca S, Sanna MP, Leoni A, et al. Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients’ geographical origin. Hum Pathol. 2008;39(2):303–304.18206499
   PubMed Web of Science ®Google Scholar
• Morozov VA, Lagaye S, Lower J, Lower R. Detection and characterization of betaretroviral sequences, related to sheep Jaagsiekte virus, in Africans from Nigeria and Cameroon.. Virology. 2004;327(2):162–168.15351203
   PubMed Web of Science ®Google Scholar
• Yousem SA, Finkelstein SD, Swalsky PA, Bakker A, Ohori NP. Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol. 2001;32(10):1039–1042.11679936
   PubMed Web of Science ®Google Scholar
• Hiatt KM, Highsmith WE. Lack of DNA evidence for jaagsiekte sheep retrovirus in human bronchioloalveolar carcinoma. Hum Pathol. 2002;33(6):680.12152170
   PubMed Web of Science ®Google Scholar
• Miller AD, De Las Heras M, Yu J, et al. Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 2017;14(1):3.28107820
   PubMedGoogle Scholar
• Berthet N, Frangeul L, Olaussen KA, et al. No evidence for viral sequences in five lepidic adenocarcinomas (former “BAC”) by a high-throughput sequencing approach. BMC Res Notes. 2015;8:782.26667652
   PubMedGoogle Scholar
• Giuliani L, Jaxmar T, Casadio C, et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007;57(3):273–281.17400331
   PubMed Web of Science ®Google Scholar
• Sinagra E, Raimondo D, Gallo E, et al. JC Virus and Lung Adenocarcinoma: fact or Myth? Anticancer Res. 2017;37(6):3311–3314.28551683
   PubMed Web of Science ®Google Scholar
• White MK, Khalili K. Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer. 2005;41(16):2537–2548.16219459
   PubMed Web of Science ®Google Scholar
• Khalili K, Del Valle L, Otte J, Weaver M, Gordon J. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene. 2003;22(33):5181–5191.12910255
   PubMed Web of Science ®Google Scholar
• Zheng H, Abdel Aziz HO, Nakanishi Y, et al. Oncogenic role of JC virus in lung cancer. J Pathol. 2007;212(3):306–315.17534844
   PubMed Web of Science ®Google Scholar
• Eash S, Tavares R, Stopa EG, Robbins SH, Brossay L, Atwood WJ. Differential distribution of the JC virus receptor-type sialic acid in normal human tissues. Am J Pathol. 2004;164(2):419–428.14742248
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HO, Murai Y, Hong M, et al. Detection of the JC virus genome in lung cancers: possible role of the T-antigen in lung oncogenesis. Applied Immunohistochemistry Mol Morphol. 2007;15(4):394–400.
   Web of Science ®Google Scholar
• Noguchi A, Kikuchi K, Ohtsu T, et al. Pulmonary tumors associated with the JC virus T-antigen in a transgenic mouse model. Oncol Rep. 2013;30(6):2603–2608.24100939
   PubMed Web of Science ®Google Scholar
• Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):E609–E16.27470177
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1–10.19720205
   PubMed Web of Science ®Google Scholar